Pathology CME

Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies
Robert Anders, MD, PhD
27 December, 2018
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do
Lynette Sholl, MD
11 December, 2018
Credits: 1.00 MOC / CME
Medical Learning Institute, Inc.
Advances and Challenges in Refining the Use of Cancer Immunotherapies Through Biomarker Testing: Practical Guidance for Pathologists on the Front Lines of the Immuno-Oncology Revolution
Kurt Schalper, MD, PhD / Edward B. Garon, MD, MS
30 November, 2018
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Anjali Saqi, MD, MBA / Geoffrey R. Oxnard, MD
29 November, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Edward Garon, MD, MS
22 November, 2018
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
Nathan Fowler, MD
9 October, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances
Kevin Flaherty, MD, MS
13 August, 2018
Credits: 0.50 CME
Penn State College of Medicine
Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Expert Insights on Current Management and Emerging Therapy
Kristin Highland, MD, MSCR
3 August, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care
Omid Hamid, MD
11 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors
George Demetri, MD
9 July, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies
Edward Garon, MD, MS
5 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management
Johanna Bendell, MD
5 July, 2018
Credits: 1.50 CME
Penn State College of Medicine
A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat
Robert Orlowski, MD, PhD
3 July, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases: Updates From San Diego
Fernando Martinez, MD, MS
27 June, 2018
Credits: 0.75 MOC / CME / 1.0 CE
Medical Learning Institute, Inc.
A Team Approach to Tackling the Complexities in Later Lines of Therapy for Metastatic Colorectal Cancer
Richard Kim, MD
30 May, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies
Matthew Hellmann, MD
29 May, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings
Anas Younes, MD
4 April, 2018
Credits: 1.50 CME / CE / CPE
Medical Learning Institute, Inc.
Solving the Multimodal Puzzle of Head & Neck Cancer in the Immunotherapy Era: How Evidence is Driving Practice Changes
Ezra Cohen, MD, FRCPC, FASCO
27 March, 2018
Credits: 1.00 CME / CE
Medical Learning Institute, Inc.
Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches
Ghassan Abou-Alfa, MD, MBA
26 March, 2018
Credits: 1.00 CME / CE
Medical Learning Institute, Inc.
Groundbreaking Treatment Options for AML: How to Personalize Patient Care With New and Emerging Therapies
Naval Daver, MD
21 March, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Quest to Win Through Science in Pancreatic Cancer: From Sequencing Current Options to Testing Novel Approaches
Andrew Ko, MD
16 March, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies
Naiyer Rizvi, MD
2 March, 2018
Credits: 0.75 CME
Medical Learning Institute, Inc.
Journal Insight on VOD/SOS: Expert Views on New Evidence and Guidelines for Disease Management
Mitchell Cairo, MD
27 February, 2018
Credits: 2.50 CME
Medical Learning Institute, Inc.
A Master Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options
Harry Erba, MD, PhD
30 January, 2018